Chemotherapy for gastric cancer

por Sastre, Javier, García-Saenz, Jose Angel, Díaz-Rubio, Eduardo
Publicado em 2006

Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemia

por Fuentes-Antrás, Jesús, de Luna, Alicia, López de Sá, Alfonso, Ocaña, Alberto, García-Sáenz, José Ángel, Moreno, Fernando
Publicado no Breast (2020)

Long-Lasting Response after Pembrolizumab in a Patient with Metastatic Triple-Negative Breast Cancer

por Peinado, Paloma, Ramírez, Carmen, García-Sáenz, José Angel, Pascual, Alejandro, Fuentes-Antrás, Jesús, Vidal, Natalia, Antoñanzas, Mónica, Moreno, Fernando
Publicado no Breast Care (Basel) (2020)

Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine

por Fuentes-Antrás, Jesús, Guevara-Hoyer, Kissy, Baliu-Piqué, Mariona, García-Sáenz, José Ángel, Pérez-Segura, Pedro, Pandiella, Atanasio, Ocaña, Alberto
Publicado no Front Oncol (2020)

Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy

por Brenes Sánchez, Juana María, Picado, Amanda López, Olivares Crespo, María Eugenia, García Sáenz, José Ángel, De La Plata Merlo, Rosa María, De La Muela, María Herrera
Publicado no Clin Breast Cancer (2021)

Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging

por García-Saenz, José Angel, Ayllón, Patricia, Laig, Marion, Acosta-Eyzaguirre, Daniel, García-Esquinas, Marta, Montes, Myriam, Sanz, Julián, Barquín, Miguel, Moreno, Fernando, Garcia-Barberan, Vanesa, Díaz-Rubio, Eduardo, Caldes, Trinidad, Romero, Atocha
Publicado no BMC Cancer (2017)

A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors

por Pérez-Pena, Javier, Tibor Fekete, Janos, Páez, Raquel, Baliu-Piqué, Mariona, García-Saenz, José Ángel, García-Barberán, Vanesa, Manzano, Aránzazu, Pérez-Segura, Pedro, Esparis-Ogando, Azucena, Pandiella, Atanasio, Gyorffy, Balázs, Ocana, Alberto
Publicado no Front Immunol (2019)

Assessment of Topoisomerase II α Status in Breast Cancer by Quantitative PCR, Gene Expression Microarrays, Immunohistochemistry, and Fluorescence in Situ Hybridization

por Romero, Atocha, Martín, Miguel, Cheang, Maggie C.U., López García-Asenjo, José Antonio, Oliva, Belén, He, Xiaping, de la Hoya, Miguel, García Sáenz, Jose Ángel, Arroyo Fernández, Manuel, Díaz Rubio, Eduardo, Perou, Charles M., Llopis, Trinidad Caldés
Publicado em 2011

GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID‐19 Pandemic in Spain

por Martin, Miguel, Guerrero‐Zotano, Angel, Montero, Ángel, Jara, Carlos, Filipovich, Elena, Rojo, Federico, Moreno, Fernando, García‐Sáenz, Jose Ángel, Alés, Jose Enrique, Chacón, José Ignacio, Cruz, Josefina, Gimenez, Julia, Cruz‐Merino, Luis, Algara, Manel, Santisteban, Marta, Tarruella, Sara López
Publicado no Oncologist (2020)

Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer

por Núñez-Torres, Rocío, Martín, Miguel, García-Sáenz, Jose Ángel, Rodrigo-Faus, María, del Monte-Millán, María, Tejera-Pérez, Hugo, Pita, Guillermo, de la Torre-Montero, Julio C., Pinilla, Karen, Herraez, Belén, Peiró-Chova, Lorena, Bermejo, Begoña, Lluch, Anna, González-Neira, Anna
Publicado no JAMA Dermatol (2020)

Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer

por Martín, Miguel, Custodio, Sara, de las Casas, Maria-Luisa Maestro, García-Sáenz, José-Ángel, de la Torre, Julio-César, Bellón-Cano, Jose-María, López-Tarruella, Sara, Vidaurreta-Lazaro, Marta, de la Orden, Virginia, Jerez, Yolanda, Márquez-Rodas, Iván, Casado, Antonio, Sastre, Javier, Díaz-Rubio, Eduardo
Publicado em 2013

Pathological response in a triple-negative breast cancer cohort treated with neoadjuvant carboplatin and docetaxel according to Lehmann’s refined classification

por Echavarria, Isabel, López-Tarruella, Sara, Picornell, Antoni, García-Saenz, Jose Ángel, Yolanda Jerez, Y, Hoadley, Katherine, Gómez, Henry L, Moreno, Fernando, Del Monte-Millan, María, Márquez-Rodas, Iván, Alvarez, Enrique, Ramos-Medina, Rocío, Gayarre, Javier, Massarrah, Tatiana, Ocaña, Inmaculada, Cebollero, María, Fuentes, Hugo, Barnadas, Agusti, Ballesteros, Ana Isabel, Bohn, Uriel, Perou, Charles M, Martin, Miguel
Publicado no Clin Cancer Res (2018)

Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study

por Lope, Virginia, Martín, Miguel, Castelló, Adela, Ruiz, Amparo, Casas, Ana Mª, Baena-Cañada, José Manuel, Antolín, Silvia, Ramos-Vázquez, Manuel, García-Sáenz, José Ángel, Muñoz, Montserrat, Lluch, Ana, de Juan-Ferré, Ana, Jara, Carlos, Sánchez-Rovira, Pedro, Antón, Antonio, Chacón, José Ignacio, Arcusa, Angels, Jimeno, Mª Angeles, Bezares, Susana, Vioque, Jesús, Carrasco, Eva, Pérez-Gómez, Beatriz, Pollán, Marina
Publicado no Sci Rep (2019)

Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype

por Lope, Virginia, Guerrero-Zotano, Ángel, Casas, Ana, Baena-Cañada, José Manuel, Bermejo, Begoña, Pérez-Gómez, Beatriz, Criado-Navarro, Inmaculada, Antolín, Silvia, Sánchez-Rovira, Pedro, Ramos-Vázquez, Manuel, Antón, Antonio, Castelló, Adela, García-Saénz, José Ángel, Muñoz, Montserrat, de Juan, Ana, Andrés, Raquel, Llombart-Cussac, Antonio, Hernando, Blanca, Franquesa, Rosa María, Caballero, Rosalia, Priego-Capote, Feliciano, Martín, Miguel, Pollán, Marina
Publicado no Nutrients (2020)

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

por Martin, Miguel, Ramos-Medina, Rocio, Bernat, Rebeca, García-Saenz, Jose Angel, del Monte-Millan, Maria, Alvarez, Enrique, Cebollero, Maria, Moreno, Fernando, Gonzalez-Haba, Eva, Bueno, Oscar, Romero, Paula, Massarrah, Tatiana, Echavarria, Isabel, Jerez, Yolanda, Herrero, Blanca, Gonzalez del Val, Ricardo, Lobato, Nerea, Rincon, Patricia, Palomero, Maria Isabel, Marquez-Rodas, Ivan, Lizarraga, Santiago, Asensio, Fernando, Lopez-Tarruella, Sara
Publicado no Sci Rep (2021)

Standard Versus Continuous Administration of Capecitabine in Metastatic Breast Cancer (GEICAM/2009-05): A Randomized, Noninferiority Phase II Trial With a Pharmacogenetic Analysis

por Martín, Miguel, Martínez, Noelia, Ramos, Manuel, Calvo, Lourdes, Lluch, Ana, Zamora, Pilar, Muñoz, Montserrat, Carrasco, Eva, Caballero, Rosalía, García-Sáenz, José Ángel, Guerra, Eva, Caronia, Daniela, Casado, Antonio, Ruíz-Borrego, Manuel, Hernando, Blanca, Chacón, José Ignacio, De la Torre-Montero, Julio César, Jimeno, María Ángeles, Heras, Lucía, Alonso, Rosario, De la Haba, Juan, Pita, Guillermo, Constenla, Manuel, González-Neira, Anna
Publicado no Oncologist (2015)

Critically short telomeres and toxicity of chemotherapy in early breast cancer

por Quintela-Fandino, Miguel, Soberon, Nora, Lluch, Ana, Manso, Luis, Calvo, Isabel, Cortes, Javier, Moreno-Antón, Fernando, Gil-Gil, Miguel, Martinez-Jánez, Noelia, Gonzalez-Martin, Antonio, Adrover, Encarna, de Andres, Raquel, Viñas, Gemma, Llombart-Cussac, Antonio, Alba, Emilio, Mouron, Silvana, Guerra, Juan, Bermejo, Begoña, Zamora, Esther, García-Saenz, Jose Angel, Simon, Sonia Pernas, Carrasco, Eva, Escudero, María José, Campo, Ruth, Colomer, Ramón, Blasco, Maria A
Publicado no Oncotarget (2017)

Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study

por Fernández de Larrea-Baz, Nerea, Pérez-Gómez, Beatriz, Guerrero-Zotano, Ángel, Casas, Ana María, Bermejo, Begoña, Baena-Cañada, José Manuel, Antolin, Silvia, Sánchez-Rovira, Pedro, Ramos Vázquez, Manuel, Garcia-Sáenz, José Ángel, Antón, Antonio, Muñoz, Montserrat, de Juan, Ana, Jara, Carlos, Chacón, José Ignacio, Arcusa, Angels, Gil-Gil, Miguel, Adrover, Encarna, Oltra, Amparo, Brunet, Joan, González, Sonia, Bezares, Susana, Lope, Virginia, Martín, Miguel, Pollán, Marina
Publicado no Sci Rep (2020)

Efficacy of neoadjuvant carboplatin plus docetaxel in triple negative breast cancer: Combined analysis of two cohorts

por Sharma, Priyanka, López-Tarruella, Sara, García-Saenz, Jose Angel, Ward, Claire, Connor, Carol S., Gómez, Henry L., Prat, Aleix, Moreno, Fernando, Jerez-Gilarranz, Yolanda, Barnadas, Augusti, Picornell, Antoni C., del Monte-Millán, Maria, Gonzalez-Rivera, Milagros, Massarrah, Tatiana, Pelaez-Lorenzo, Beatriz, Palomero, María Isabel, González del Val, Ricardo, Cortes, Javier, Fuentes, Hugo, Bretel, Denisse, Márquez-Rodas, Iván, Perou, Charles M., Wagner, Jamie L., Mammen, Joshua V., McGinness, Marilee K., Klemp, Jennifer R., Amin, Amanda L., Fabian, Carol J., Heldstab, Jaimie, Godwin, Andrew K., Jensen, Roy A., Kimler, Bruce F., Khan, Qamar J., Martin, Miguel
Publicado no Clin Cancer Res (2016)

Pathological response and survival in triple-negative breast cancer following neoadjuvant carboplatin plus docetaxel

por Sharma, Priyanka, López-Tarruella, Sara, García-Saenz, José Angel, Khan, Qamar J., Gómez, Henry L., Prat, Aleix, Moreno, Fernando, Jerez-Gilarranz, Yolanda, Barnadas, Agustí, Picornell, Antoni C., del Monte-Millán, María, González-Rivera, Milagros, Massarrah, Tatiana, Pelaez-Lorenzo, Beatriz, Palomero, María Isabel, González del Val, Ricardo, Cortés, Javier, Rivera, Hugo Fuentes, Morales, Denisse Bretel, Márquez-Rodas, Iván, Perou, Charles M., Lehn, Carolyn, Wang, Yen Y., Klemp, Jennifer R., Mammen, Joshua V., Wagner, Jamie L., Amin, Amanda L., O’Dea, Anne P., Heldstab, Jaimie, Jensen, Roy A., Kimler, Bruce F., Godwin, Andrew K., Martín, Miguel
Publicado no Clin Cancer Res (2018)